Menu

Sun Pharma

Equity Right Ola Financial Services

SFPL gives up NBFC dreams. Renounces the licence

Mr Dilip Shanghvi's investment company Shanghvi Finance Pvt Ltd (SFPL) has surrendered their NBFC license. The investment company is a unit of Dilip Shanghvi Group. The group is also responsible...
Indian Pharma to gain from Trump 2.0

Revival plan in motion, Sun Pharma plans to develop its own patent drugs

Mr Dilip Sanghvi, the MD & CEO of Sun Pharmaceutical Industries Ltd., has decided to go forward with the company operations with a fresh perspective. Sun Pharma is planning to...